Article History
Received: 28 January 2026
Accepted: 6 July 2026
First Online: 16 July 2026
Declarations
Ethics approval and consent to participate: The study protocol was reviewed and approved by the Institutional Review Board (IRB) of Samsung Medical Center (Approval No. 2023-11-105), registered as a clinical trial (ClinicalTrials.gov Identifier: NCT07397767), and conducted in accordance with the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.